The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique. (Q39887622)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

Schistosoma haematobium

0 references

1 reference

based on heuristic

inferred from title

Pascal Magnussen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Birgitte J Vennervald

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

G Augusto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

T K Kristensen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C C Appleton

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 June 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

136

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1771-1779

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Efficacy of artesunate in the treatment of urinary schistosomiasis, in an endemic community in Nigeria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Towards an understanding of the mechanism of action of praziquantel

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Schistosoma mansoni: chemotherapy of infections of different ages

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

The immune dependence of chemotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Schistosomiasis haematobia: histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

21 January 2018

Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the coast province of Kenya

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

7 January 2021

based on heuristic

inferred from DOI database lookup

Drugs for treating urinary schistosomiasis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

7 January 2021

based on heuristic

inferred from DOI database lookup

Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of praziquantel against schistosomiasis: a review of current status.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of praziquantel against Schistosoma haematobium infection in children.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of schistosomiasis: an update

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006210

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0031182009006210

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19490727%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39887622&oldid=2092122710"